Liposomal topoisomerase I inhibitor

This page covers all Liposomal topoisomerase I inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Topoisomerase I.

Targets

Topoisomerase I

Phase 3 pipeline (1)

• MM-398 · Ipsen · Oncology
  MM-398 is a liposomal formulation of irinotecan that delivers the topoisomerase I inhibitor directly to tumor cells while reducing systemic toxicity.